Impact of mydriatic eye drops on neonatal cerebral blood flow

@inproceedings{Alshafei2017ImpactOM,
  title={Impact of mydriatic eye drops on neonatal cerebral blood flow},
  author={Atef Alshafei and Mahmoud Ayman Hassaan Ahmed and Shymaa Farouk and Ahmed M. Gouda and Anwar Ibrahim Khan and Rashid Mustafa},
  year={2017}
}
  • Atef Alshafei, Mahmoud Ayman Hassaan Ahmed, +3 authors Rashid Mustafa
  • Published 2017
  • Medicine
  • Retinopathy of prematurity (ROP) screening is a common routine procedure carried out on preterm infants in neonatal intensive care units (NICUs). Mydriatic eye drops containing phenylephrine hydrochloride 2.5% (a sympathomimetic agent) and tropicamide 0.5% (a cycloplegic medication) are readily absorbed from the conjunctiva and produce systemic responses in various organs. To our knowledge, no studies have investigated the direct effects of these medications on cerebral blood flow velocities… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 39 REFERENCES

    Fatal necrotising enterocolitis due to mydriatic eye drops.

    VIEW 1 EXCERPT

    Retinopathy of prematurity-incidence today.

    VIEW 1 EXCERPT